RPS Urges Clearer Warnings on Nasal Decongestant Spray Overuse Risks

The Royal Pharmaceutical Society (RPS) has highlighted the need for improved public awareness regarding the risks associated with nasal decongestant sprays. A recent survey conducted among 309 community pharmacists revealed concerning trends in the overuse of these treatments.

Survey Findings on Nasal Decongestant Spray Use

• 63% of pharmacists have intervened in cases of suspected overuse.
• 59% believe patients are unaware of the risks linked to rebound congestion.
• 74% of respondents indicated that packaging should have clearer warnings about the seven-day usage limit.

Risks of Prolonged Use

Nasal decongestant sprays containing xylometazoline or oxymetazoline should only be used for a maximum of seven consecutive days. This guideline is supported by both the NHS and manufacturers. Prolonged use can lead to rhinitis medicamentosa, commonly known as rebound congestion, which creates a dependency on the sprays for relief.

Amira Guirguis, chief scientist at the RPS, emphasized, “Using these sprays beyond seven days can worsen congestion. Many individuals remain unaware of this risk, potentially extending their symptoms unwittingly.”

Importance of Clear Warnings

To mitigate these risks, Guirguis calls for noticeable warnings on product packaging. She advises patients that if their congestion persists for over a week, they should consult a pharmacist for safer alternatives.

Olivier Picard, chair of the National Pharmacy Association, echoed these sentiments. He pointed out that the risks of side effects increase with overuse, leading pharmacists to sometimes refuse to sell these sprays to protect patients from misuse.

Safe Alternatives and Professional Guidance

Many individuals may inadvertently purchase nasal decongestants without understanding the potential side effects or usage guidelines. Pharmacists play a crucial role in offering expert advice on safe medication practices.

• Consult with a pharmacist if symptoms continue beyond seven days.
• Explore safe and effective alternatives for managing congestion.
• Understand that pharmacists can provide tailored advice regarding medications.

In summary, the RPS’s findings prompt a call for heightened awareness and clearer communication regarding the safe use of nasal decongestant sprays to prevent unnecessary health risks. As health experts, pharmacists remain accessible resources for patients seeking clarity and guidance on medication use.